PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Sheila Bingham Selected Research
Neoplasms (Cancer)
10/2008
Lack of Prospective Associations between Plasma and Urinary Phytoestrogens and Risk of Prostate or Colorectal Cancer in the European Prospective into Cancer-Norfolk Study.
08/2008
Cross-sectional study on acrylamide hemoglobin adducts in subpopulations from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.
07/2008
Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).
06/2008
Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).
05/2008
Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition.
02/2008
Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study.
01/2008
Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study.
12/2007
Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study.
11/2007
The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition.
10/2007
Dietary carbohydrates, glycemic index, glycemic load, and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition cohort.
09/2007
Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition.
09/2007
Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study.
09/2007
Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
08/2007
Epidemiologic assessment of sugars consumption using biomarkers: comparisons of obese and nonobese individuals in the European prospective investigation of cancer Norfolk.
07/2007
Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition.
06/2007
Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.
06/2007
Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition.
05/2007
Usual physical activity and endogenous sex hormones in postmenopausal women: the European prospective investigation into cancer-norfolk population study.
03/2007
Haplotype-based analysis of common variation in the acetyl-coA carboxylase alpha gene and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition.
01/2007
Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
12/2006
Ethanol intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
12/2006
Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition.
11/2006
Tobacco smoke and bladder cancer--in the European Prospective Investigation into Cancer and Nutrition.
11/2006
Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
08/2006
Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
07/2006
Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study.
05/2006
No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition.
12/2005
Plasma ascorbic acid concentrations and fat distribution in 19,068 British men and women in the European Prospective Investigation into Cancer and Nutrition Norfolk cohort study.
07/2005
Long-term cryoconservation and stability of vitamin C in serum samples of the European prospective investigation into cancer and nutrition.
06/2005
C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
05/2005
Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
04/2005
Fibrinogen and cigarette smoking in men and women in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population.
11/2004
Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk).
09/2004
Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.
09/2004
Plasma levels of six carotenoids in nine European countries: report from the European Prospective Investigation into Cancer and Nutrition (EPIC).
06/2004
Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study.
08/2003
Group level validation of protein intakes estimated by 24-hour diet recall and dietary questionnaires against 24-hour urinary nitrogen in the European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study.
Articles by Research Topic
Disease
37
Neoplasms (Cancer)
10/2008 - 08/2003
6
Breast Neoplasms (Breast Cancer)
07/2008 - 05/2005
5
Endometrial Neoplasms (Endometrial Cancer)
06/2008 - 01/2007
5
Prostatic Neoplasms (Prostate Cancer)
05/2008 - 06/2007
4
Stomach Neoplasms (Stomach Cancer)
11/2007 - 07/2006
3
Colorectal Neoplasms (Colorectal Cancer)
10/2008 - 06/2002
2
Lung Neoplasms (Lung Cancer)
04/2008 - 12/2006
2
Cardiovascular Diseases (Cardiovascular Disease)
12/2007 - 09/2004
1
Heart Diseases (Heart Disease)
10/2008
1
Gallstones (Gallstone)
01/2008
1
Syndrome
09/2007
1
Rectal Neoplasms (Rectal Cancer)
07/2007
1
Coronary Disease (Coronary Heart Disease)
01/2007
1
Ovarian Neoplasms (Ovarian Cancer)
01/2007
1
Urinary Bladder Neoplasms (Bladder Cancer)
11/2006
1
Adenocarcinoma
05/2006
Drug/Important Bio-Agent (IBA)
4
C-Peptide
IBA
07/2007 - 06/2005
3
Biological Markers (Surrogate Marker)
IBA
10/2008 - 08/2007
3
Hemoglobins (Hemoglobin)
IBA
08/2008 - 06/2004
3
Insulin-Like Growth Factor I (IGF-1)
IBA
07/2008 - 06/2005
3
Gonadal Steroid Hormones (Sex Hormones)
IBA
06/2008 - 06/2005
3
Ascorbic Acid (Vitamin C)
FDA Link
Generic
11/2006 - 07/2005
2
Phytoestrogens (Phytoestrogen)
IBA
10/2008 - 01/2008
2
Vitamin B 12 (Cyanocobalamin)
FDA Link
Generic
02/2008 - 11/2007
2
Androgens
IBA
09/2007 - 01/2007
2
Carotenoids (Carotene)
IBA
09/2007 - 09/2004
2
Insulin-Like Growth Factor Binding Protein 1
IBA
07/2007 - 06/2007
2
Insulin-Like Growth Factor Binding Protein 2
IBA
07/2007 - 06/2007
2
Smoke
IBA
12/2006 - 11/2006
2
Steroids
IBA
06/2006 - 05/2005
1
Insulin-Like Growth Factor Binding Protein 3
IBA
07/2008
1
Ghrelin
IBA
07/2008
1
Dietary Fats (Ghee)
IBA
05/2008
1
Nicotinic Receptors (Nicotinic Acetylcholine Receptor)
IBA
04/2008
1
Testosterone (Sustanon)
FDA Link
Generic
12/2007
1
Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)
IBA
11/2007
1
Dietary Carbohydrates (Carbohydrate, Dietary)
IBA
10/2007
1
Lipoproteins (Lipoprotein)
IBA
09/2007
1
Tocopherols
FDA Link
09/2007
1
Glucose (Dextrose)
FDA Link
Generic
09/2007
1
Vitamin A (Retinol)
FDA Link
09/2007
1
Carbohydrates
IBA
08/2007
1
Insulin (Novolin)
FDA Link
06/2007
1
Acetyl-CoA Carboxylase
IBA
03/2007
1
Triglycerides (Triacylglycerol)
IBA
01/2007
1
Adiponectin
IBA
01/2007
1
Ethanol (Ethyl Alcohol)
IBA
12/2006
1
Nitroso Compounds
IBA
07/2006
1
Cytochrome P-450 CYP2E1 (CYP2E1)
IBA
05/2006
1
Fibrinogen (Factor I)
IBA
04/2005
1
Sodium
IBA
11/2004
1
Nitrogen
IBA
08/2003
1
Proteins (Proteins, Gene)
IBA
06/2002
Therapy/Procedure
1
Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2008